Literature DB >> 20947846

Anamnestic recall of stroke-related deficits: an animal model.

Dannielle Zierath1, Jessica Hadwin, Anna Savos, Kelly T Carter, Allison Kunze, Kyra J Becker.   

Abstract

BACKGROUND AND
PURPOSE: Anamnestic recall of stroke-related deficits is a common clinical observation, especially during periods of systemic infection. The pathophysiology of this transient re-emergence of neurological dysfunction is unknown.
METHODS: Male Lewis rats underwent 3 hours middle cerebral artery occlusion and were treated with lipopolysaccharide or saline at the time of reperfusion. The delayed-type hypersensitivity (DTH) response to myelin basic protein was examined 28 days after middle cerebral artery occlusion. Changes in behavioral outcomes were assessed after DTH testing and repeat administration of lipopolysaccharide or saline at 34 days. At the time of euthanasia (36 days), the immunologic response of splenocytes to myelin basic protein, neuron-specific enolase, and proteolipid protein was determined by enzyme-linked immunospot assay and the number of lymphocytes in the brain determined by immunocytochemistry.
RESULTS: Animals treated with lipopolysaccharide at middle cerebral artery occlusion had a greater DTH response to myelin basic protein than animals treated with saline. Among those animals that had fully recovered on a given behavioral test before DTH testing, those treated with lipopolysaccharide at middle cerebral artery occlusion displayed more neurological deterioration after DTH testing and had more CD8(+) lymphocytes within the ischemic core of the brain. Furthermore, the Th1 immune response to brain antigens in the spleen was more robust among those animals that deteriorated after DTH testing and there were more CD4(+) lymphocytes in the penumbral region of animals with a Th1 response to myelin basic protein.
CONCLUSIONS: Our data suggest that an immune response to the brain contributes to the phenomenon of anamnestic recall of stroke-related deficits after an infection. The contribution of the immune response to this phenomenon deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947846      PMCID: PMC3017560          DOI: 10.1161/STROKEAHA.110.592865

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  29 in total

Review 1.  Basic principles of immunological surveillance of the normal central nervous system.

Authors:  W F Hickey
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

Review 2.  Cellular antimicrobial immunity.

Authors:  F M Collins
Journal:  CRC Crit Rev Microbiol       Date:  1978

Review 3.  Regulatory T cells in spontaneous autoimmune encephalomyelitis.

Authors:  G C Furtado; D Olivares-Villagómez; M A Curotto de Lafaille; A K Wensky; J A Latkowski; J J Lafaille
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

4.  Impaired motor activity and motor learning function in rat with middle cerebral artery occlusion.

Authors:  Yuchuan Ding; Yandong Zhou; Qin Lai; Jie Li; Hun Park; Fernando G Diaz
Journal:  Behav Brain Res       Date:  2002-04-15       Impact factor: 3.332

5.  Functional assessments in mice and rats after focal stroke.

Authors:  A J Hunter; J Hatcher; D Virley; P Nelson; E Irving; S J Hadingham; A A Parsons
Journal:  Neuropharmacology       Date:  2000-03-03       Impact factor: 5.250

6.  Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?

Authors:  Kyra Becker; Darin Kindrick; Richard McCarron; John Hallenbeck; Robert Winn
Journal:  Stroke       Date:  2003-06-05       Impact factor: 7.914

7.  CNS immune responses following experimental stroke.

Authors:  Dannielle Zierath; Matthew Thullbery; Jessica Hadwin; J Michael Gee; Anna Savos; Angela Kalil; Kyra J Becker
Journal:  Neurocrit Care       Date:  2009-08-28       Impact factor: 3.210

8.  Early biomarkers of stroke.

Authors:  Mark A Reynolds; Howard J Kirchick; Jeffrey R Dahlen; Joseph M Anderberg; Paul H McPherson; Kevin K Nakamura; Daniel T Laskowitz; Gunars E Valkirs; Kenneth F Buechler
Journal:  Clin Chem       Date:  2003-10       Impact factor: 8.327

9.  Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.

Authors:  J R Richert; B F Driscoll; M W Kies; E C Alvord
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

10.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

Authors:  J B Bederson; L H Pitts; M Tsuji; M C Nishimura; R L Davis; H Bartkowski
Journal:  Stroke       Date:  1986 May-Jun       Impact factor: 7.914

View more
  11 in total

1.  Autoimmune responses to brain following stroke.

Authors:  Kyra Becker
Journal:  Transl Stroke Res       Date:  2012-04-05       Impact factor: 6.829

2.  Recrudescence of Deficits After Stroke: Clinical and Imaging Phenotype, Triggers, and Risk Factors.

Authors:  Mehmet A Topcuoglu; Esen Saka; Scott B Silverman; Lee H Schwamm; Aneesh B Singhal
Journal:  JAMA Neurol       Date:  2017-09-01       Impact factor: 18.302

3.  Promiscuity of autoimmune responses to MBP after stroke.

Authors:  Dannielle Zierath; Allison Kunze; Leia Fecteau; Kyra Becker
Journal:  J Neuroimmunol       Date:  2015-05-28       Impact factor: 3.478

4.  Neuroprotection after cerebral ischemia.

Authors:  Shobu Namura; Hiroaki Ooboshi; Jialing Liu; Midori A Yenari
Journal:  Ann N Y Acad Sci       Date:  2013-03       Impact factor: 5.691

5.  Recrudescence of Old Stroke Deficits Among Transient Neurological Attacks.

Authors:  Adalia H Jun-O'connell; Nils Henninger; Majaz Moonis; Brian Silver; Carolina Ionete; Richard P Goddeau
Journal:  Neurohospitalist       Date:  2019-02-21

6.  Expression profiles of microRNAs after focal cerebral ischemia/reperfusion injury in rats.

Authors:  Fengguo Zhai; Xiuping Zhang; Yue Guan; Xudong Yang; Yang Li; Gaochen Song; Lixin Guan
Journal:  Neural Regen Res       Date:  2012-04-25       Impact factor: 5.135

7.  Relationship of gelatinases-tight junction proteins and blood-brain barrier permeability in the early stage of cerebral ischemia and reperfusion.

Authors:  Haolin Xin; Wenzhao Liang; Jing Mang; Lina Lin; Na Guo; Feng Zhang; Zhongxin Xu
Journal:  Neural Regen Res       Date:  2012-11-05       Impact factor: 5.135

8.  Neuroprotective Effect of the Ginsenoside Rg1 on Cerebral Ischemic Injury In Vivo and In Vitro Is Mediated by PPARγ-Regulated Antioxidative and Anti-Inflammatory Pathways.

Authors:  Yang Li; Yue Guan; Ying Wang; Chun-Lei Yu; Feng-Guo Zhai; Li-Xin Guan
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-01       Impact factor: 2.629

9.  Buyang Huanwu Decoction fraction protects against cerebral ischemia/reperfusion injury by attenuating the inflammatory response and cellular apoptosis.

Authors:  Yulian Jin; Liuyi Dong; Changqing Wu; Jiang Qin; Sheng Li; Chunyan Wang; Xu Shao; Dake Huang
Journal:  Neural Regen Res       Date:  2013-01-25       Impact factor: 5.135

10.  Neuronal Interleukin-4 as a Modulator of Microglial Pathways and Ischemic Brain Damage.

Authors:  Xiurong Zhao; Huan Wang; Guanghua Sun; Jie Zhang; Nancy J Edwards; Jaroslaw Aronowski
Journal:  J Neurosci       Date:  2015-08-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.